Guidant Solution To Panel Dilemma Will Not Require New Contak Implants
This article was originally published in The Gray Sheet
Executive Summary
Guidant's Contak CD "continued access policy" IDE could augment the company's pivotal trial and allow the firm to avoid returning for a second review by the Circulatory System Devices Panel.